help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ankarberg-Lindgren, C.
Right arrow Articles by Norjavaara, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ankarberg-Lindgren, C.
Right arrow Articles by Norjavaara, E.
The Journal of Clinical Endocrinology & Metabolism Vol. 86, No. 7 3039-3044
Copyright © 2001 by The Endocrine Society


Endocrine Care

Nocturnal Application of Transdermal Estradiol Patches Produces Levels of Estradiol That Mimic Those Seen at the Onset of Spontaneous Puberty in Girls1

Carina Ankarberg-Lindgren, Maria Elfving, Kerstin Albertsson Wikland and Ensio Norjavaara

Göteborg Pediatric Growth Research Center, Institute for the Health of Women and Children, Göteborg University (C.A.-L., M.E., K.A.W., E.N.), S-416 85 Göteborg; and Department of Pediatrics, Lund University (M.E.), 221 85 Lund, Sweden

Address all correspondence and requests for reprints to: Dr. Ensio Norjavaara, Queen Silvia Children’s Hospital, Göteborg University, Institute for the Health of Women and Children, Göteborg Pediatric Growth Research Center, S-416 85 Göteborg, Sweden. E-mail: ensio.norjavaara{at}astrazeneca.com

Abstract

The objective of pubertal induction in children with hypogonadism is to mimic spontaneous puberty in terms of physical and psychological development. In a clinical observation study, we induced puberty in 15 girls with hyper- or hypogonadotropic hypogonadism using low doses of transdermal estradiol patches attached only during the night and compared the estradiol concentrations obtained with those in healthy girls. Pubertal induction was started between the ages of 12.3 and 18.1 yr. A transdermal matrix patch of 17ß-estradiol (25 µg/24 h; Evorel, Janssen Pharmaceuticals-Cilag) was cut into pieces corresponding to 3.1, 4.2, or 6.2 µg/24 h initially and attached to the buttock. After 4–14 months, the dose was increased gradually. Serum 17ß-estradiol concentrations were measured every 2 h by RIA (detection limit, 6.0 pmol/L; 1.6 pg/mL).

The results show that it is possible to mimic the spontaneous levels as well as the diurnal pattern of serum 17ß-estradiol in early puberty, by cutting a transdermal 17ß-estradiol matrix patch and attaching a part of it, corresponding to 0.08–0.12 µg estradiol/kg BW, to the buttock nocturnally. In most of the girls, breast development occurred within 3–6 months of the start of treatment.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
C. Ankarberg-Lindgren and E. Norjavaara
A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17 -estradiol in prepubertal children
Eur. J. Endocrinol., January 1, 2008; 158(1): 117 - 124.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Bondy and for The Turner Syndrome Consensus Study Group
Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group
J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 10 - 25.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. L. Rosenfield, N. Devine, J. J. Hunold, N. Mauras, T. Moshang Jr., and A. W. Root
Salutary Effects of Combining Early Very Low-Dose Systemic Estradiol with Growth Hormone Therapy in Girls with Turner Syndrome
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6424 - 6430.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Soriano-Guillen, J. Coste, E. Ecosse, J. Leger, M. Tauber, S. Cabrol, M. Nicolino, R. Brauner, the StaTur Study Group, J.-L. Chaussain, et al.
Adult Height and Pubertal Growth in Turner Syndrome after Treatment with Recombinant Growth Hormone
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5197 - 5204.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Piippo, H. Lenko, P. Kainulainen, and I. Sipila
Use of Percutaneous Estrogen Gel for Induction of Puberty in Girls with Turner Syndrome
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3241 - 3247.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society